CANDICE BERTSCH: Open Payments
NPI 1841920030 · DOTHAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,310 in 110 payments from 45 companies in 2025. Trend: 2023 $2,170 · 2024 $2,986 · 2025 $2,310
Food & beverage: $2,310
| Company | Payments | Amount |
|---|---|---|
| Genentech USA, Inc. | 11 | $213 |
| Incyte Corporation | 6 | $164 |
| Daiichi Sankyo Inc. | 7 | $153 |
| Novartis Pharmaceuticals Corporation | 5 | $119 |
| Janssen Biotech, Inc. | 6 | $112 |
| AstraZeneca Pharmaceuticals LP | 6 | $108 |
| E.R. Squibb & Sons, L.L.C. | 5 | $108 |
| Merck Sharp & Dohme LLC | 4 | $95 |
| Celgene Corporation | 4 | $81 |
| Regeneron Healthcare Solutions, Inc. | 3 | $71 |
Products named: OPDIVO, Enhertu, KEYTRUDA, Monjuvi, BRUKINSA, Tecentriq, ERLEADA, JAKAFI.
Industry payments across AL — which companies pay providers there.
